The GLP-1 Receptor Agonist market is estimated to be valued at US$ 14319.85 Mn in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. GLP-1 receptor agonists are injectable drugs used for the treatment of type 2 diabetes. They work by increasing insulin secretion, decreasing glucagon...
0 Commentarios
0 Acciones
1251 Views
0 Vista previa
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian